|
GCC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.13737924528823E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.68249858489844E-11 |
| Normal-vs-Stage2 |
9.591400E-04 |
| Normal-vs-Stage3 |
8.57047766089636E-12 |
| Normal-vs-Stage4 |
2.96689994794264E-09 |
| Stage1-vs-Stage2 |
4.588000E-02 |
| Stage1-vs-Stage3 |
1.716960E-01 |
| Stage1-vs-Stage4 |
1.499550E-01 |
| Stage2-vs-Stage3 |
8.323100E-03 |
| Stage2-vs-Stage4 |
1.494270E-02 |
| Stage3-vs-Stage4 |
7.048600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.16247028564476E-12 |
| Normal-vs-AfricanAmerican |
1.0760000002108E-08 |
| Normal-vs-Asian |
4.5292000039332E-08 |
| Caucasian-vs-AfricanAmerican |
4.828400E-01 |
| Caucasian-vs-Asian |
9.716800E-01 |
| AfricanAmerican-vs-Asian |
6.400600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.25088869554702E-12 |
| Normal-vs-Female |
3.64870356150959E-11 |
| Male-vs-Female |
2.423400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.40499858811449E-11 |
| Normal-vs-Age(41-60Yrs) |
5.55040458039002E-11 |
| Normal-vs-Age(61-80Yrs) |
2.29819996366842E-09 |
| Normal-vs-Age(81-100Yrs) |
4.998500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.778800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.087600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.413400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.229400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.758000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.920000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.263700E-02 |
| Classical-VS-Follicular |
5.062600E-01 |
| Classical-VS-Other |
8.365700E-02 |
| Classical-VS-Normal |
3.96399579827289E-11 |
| Tall-VS-Follicular |
1.459960E-01 |
| Tall-VS-Other |
5.061200E-01 |
| Tall-VS-Normal |
2.40810005269765E-09 |
| Follicular-VS-Other |
2.751400E-01 |
| Follicular-VS-Normal |
2.90320000040367E-07 |
| Other-VS-Normal |
1.151110E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.52870005543093E-09 |
| Normal-vs-N1 |
2.612400296087E-10 |
| N0-vs-N1 |
9.483300E-03 |
|
|
